Since its launch, Rezdiffra has made steady commercial progress. In the third quarter, Madrigal's single approved product ...

Abivax is preparing a regulatory submission in the U.S. in the second half of 2026, provided an ongoing maintenance trial ...

Virgin Galactic is not in a good place right now. The company's spending $460 million annually in cash burn to develop a new ...

Since tech and AI stocks began outperforming the S&P 500 about three years ago, questions about their high valuations have ...

The stock market continued to churn on Tuesday, as investors largely remained in a holding pattern as they wait to discover ...

For its first few years of existence, Lucid had just one model: the Air luxury sedan. On balance, the Air is a solid product.

UnitedHealth Group is far from the perfect stock, but it is an appealing buy because it can learn from its errors and ...

Lithium prices have hit 18-month highs. A major Chinese producer believes lithium prices could double. If Sigma Lithium can ...

Richmond appears to have taken a quick profit from holding SDVY over the last year, but the ETF remains its tenth-largest ...

For each month you claim benefits before your full retirement age, you shrink your checks. The reduction adds up to a 6.7% ...

Oklo 's ( OKLO +1.69%) stock has hit a rough patch. After soaring by 720% since Jan. 1, the nuclear start-up's shares hit a ...

Over the past six months, Tesla ( TSLA +2.10%) and Alphabet ( GOOGL +1.17%) have both delivered eye-catching gains as ...